David Davidson, Chief Medical Officer at bluebird bio, Inc. (BLUE), sold 14,620 shares at $128.28 ($1.9M) on 2019-07-05, disclosed to the SEC on 2019-07-09.
Seasonal sale ($1.9M) by Chief Medical Officer — this insider has traded BLUE in July in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $128.28 | 2,828 | $363K | 19.2% |
| 2 | $128.28 | 2,828 | $363K | 19.2% |
| 3 | $129.32 | 832 | $108K | 5.7% |
| 4 | $129.32 | 832 | $108K | 5.7% |
| 5 | $130.05 | 3,300 | $429K | 22.7% |
| 6 | $130.05 | 3,300 |
| $429K |
| 22.7% |
| 7 | $131.77 | 700 | $92K | 4.9% |
| Total | $129.36 avg | 14,620 | $1.9M | 100% |
| Filing → |
| BLUE | SELL | 2021-02-18 | $20K | — | Filing → |
| BLUE | SELL | 2021-02-04 | $3K | — | Filing → |
| BLUE | SELL | 2021-01-08 | $288K | — | Filing → |